Akio Morinobu Selected Research

Rheumatoid Vasculitis

11/2019	Glucocorticoid-sensitive Paroxysmal Atrial Fibrillation, Sick Sinus Syndrome, and Mitral Regurgitation in a Patient with Malignant Rheumatoid Vasculitis.
1/2019	Acute Pulmonary Hypertension Crisis after Adalimumab Reduction in Rheumatoid Vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akio Morinobu Research Topics

Disease

33	Rheumatoid Arthritis 11/2022 - 02/2002
11	Arthritis (Polyarthritis) 01/2022 - 07/2008
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2007
5	Rheumatic Diseases (Rheumatism) 07/2022 - 08/2002
5	Infections 02/2022 - 10/2003
5	Inflammation (Inflammations) 01/2022 - 01/2018
4	Dermatomyositis (Dermatopolymyositis) 11/2022 - 04/2011
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2008
4	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 04/2011
4	Fever (Fevers) 06/2018 - 01/2008
3	Polymyositis 11/2022 - 04/2011
3	Bone Resorption 01/2022 - 07/2008
3	Fibrosis (Cirrhosis) 01/2021 - 01/2016
2	Osteoporosis 07/2022 - 08/2002
2	Leukocytosis (Pleocytosis) 04/2022 - 01/2006
2	Thrombocytopenia (Thrombopenia) 04/2022 - 06/2018
2	Hypertension (High Blood Pressure) 01/2021 - 01/2021
2	Rheumatoid Vasculitis 11/2019 - 01/2019
2	Pericardial Effusion 11/2019 - 09/2017
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 05/2015
2	Neoplasms (Cancer) 11/2017 - 12/2011
2	Mixed Connective Tissue Disease (MCTD) 05/2015 - 04/2011
1	Neutropenia 11/2022
1	Myalgia 11/2022
1	Muscular Dystrophies (Muscular Dystrophy) 11/2022
1	Transverse Myelitis (Necrotizing Myelitis) 04/2022
1	Encephalomyelitis (Myeloencephalitis) 04/2022
1	Surgical Wound Infection 02/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2022
1	Diabetes Mellitus 02/2022
1	Pain (Aches) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Hyperplasia 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Sarcopenia 10/2021
1	Uveitis 05/2021

Drug/Important Bio-Agent (IBA)

7	Biological ProductsIBA 02/2022 - 09/2010
6	Antirheumatic Agents (DMARD)IBA 02/2022 - 09/2010
5	AutoantibodiesIBA 01/2022 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 02/2002
4	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 03/2010
4	Prednisolone (Predate)FDA LinkGeneric 04/2022 - 01/2008
4	AntibodiesIBA 01/2022 - 06/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
4	C-Reactive ProteinIBA 12/2021 - 01/2008
4	InterleukinsIBA 01/2018 - 10/2003
3	tocilizumab (atlizumab)FDA Link 11/2022 - 06/2018
3	EnzymesIBA 03/2021 - 03/2018
3	CollagenIBA 01/2021 - 07/2008
3	Janus Kinase InhibitorsIBA 12/2020 - 04/2015
3	tofacitinibIBA 11/2020 - 04/2015
3	GlucocorticoidsIBA 11/2019 - 06/2017
2	Monoclonal AntibodiesIBA 07/2022 - 07/2008
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2022 - 06/2018
2	Pharmaceutical PreparationsIBA 03/2022 - 03/2022
2	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2022
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 09/2002
2	LipidsIBA 01/2022 - 01/2021
2	Adalimumab (Humira)FDA Link 05/2021 - 01/2019
2	ImmunosorbentsIBA 03/2021 - 03/2018
2	CytokinesIBA 01/2020 - 01/2018
2	Antigen-Antibody Complex (Immune Complex)IBA 11/2019 - 06/2019
2	Glutamine (L-Glutamine)FDA Link 01/2019 - 11/2017
2	Interleukin-6 (Interleukin 6)IBA 06/2018 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 09/2012
2	Immunoglobulins (Immunoglobulin)IBA 09/2017 - 10/2015
2	Interleukin-10 (Interleukin 10)IBA 09/2017 - 03/2010
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2016 - 02/2004
2	Immunoglobulin G (IgG)IBA 10/2015 - 03/2010
2	Growth Hormone (Somatotropin)IBA 10/2015 - 01/2011
2	ZymosanIBA 04/2015 - 05/2011
2	Histone Deacetylase InhibitorsIBA 05/2011 - 06/2006
2	Histone Deacetylases (Histone Deacetylase)IBA 05/2011 - 08/2009
2	trichostatin A (A 300)IBA 05/2011 - 06/2006
2	Rheumatoid FactorIBA 09/2010 - 06/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2008 - 08/2002
2	Anti-Citrullinated Protein AntibodiesIBA 06/2007 - 04/2007
2	cyclic citrullinated peptideIBA 06/2007 - 04/2007
1	Branched-Chain Amino AcidsIBA 11/2022
1	plexinIBA 11/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2022
1	Denosumab FDA Link 07/2022
1	Biosimilar PharmaceuticalsIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Immunoglobulin FragmentsIBA 01/2022
1	Sterol Regulatory Element Binding ProteinsIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2022
1	fatostatinIBA 01/2022
1	hydroxide ionIBA 10/2021
1	Vitamin D FDA LinkGeneric 10/2021
1	25-hydroxyvitamin DIBA 10/2021

Therapy/Procedure

9	Therapeutics 02/2022 - 08/2002
1	Orthopedic Procedures 02/2022
1	Operative Time 02/2022
1	Replacement Arthroplasty 01/2022
1	Exercise Therapy (Therapy, Exercise) 01/2022